1220. Comparing Breakthrough Fungal Infections in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients Receiving Prophylaxis with Different Azoles

BACKGROUND: Posaconazole is recommended for primary prophylaxis in neutropenic patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) receiving induction chemotherapy. Despite prophylaxis, breakthrough invasive fungal infections (bIFIs) still arise. Initiating posaconazole is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Catherine, Tverdek, Frank P, Escobar, Zahra, Liu, Catherine, Simmons, William F, Bui, Hanh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677763/
http://dx.doi.org/10.1093/ofid/ofad500.1060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677763/
http://dx.doi.org/10.1093/ofid/ofad500.1060

Ejemplares similares